Patents Assigned to HenKan Pharmaceutical Co., Ltd.
  • Pharmaceutical Composition for Treating Cancers
    Publication number: 20120058961
    Abstract: The preset invention relates to a new approach for treating cancer by using a synergistic combination of a histone deacetylase inhibitor and a furost-5-ene-3,22,26-triol glycoside. A pharmaceutical composition for treating a cancer comprising the synergistic combination and the treatment of a cancer with the synergistic combination are provided.
    Type: Application
    Filed: September 8, 2010
    Publication date: March 8, 2012
    Applicant: HENKAN PHARMACEUTICAL CO., LTD.
    Inventor: John Soong
  • FUROST-5-ENE-3, 22, 26-TRIOL GLYCOSIDE COMPOUND FOR PREVENTING AND TREATMENT CANCER
    Publication number: 20100179098
    Abstract: A pharmaceutical composition for preventing and treating cancer comprising furost-5-ene-3,22,26-triol glycoside, which can be used to prevent and treat cancer by promoting apoptosis.
    Type: Application
    Filed: September 7, 2006
    Publication date: July 15, 2010
    Applicant: HENKAN PHARMACEUTICAL CO., LTD.
    Inventors: Shoei-Sheng Lee, Ming-Yang Lai, Chien-Kuang Chen, Chih-Chiang Wang
  • Topical composition for transdermal administration
    Patent number: 7655255
    Abstract: The present invention relates to a topical composition for transdermal administration, wherein main components of the composition comprises vitamin C, vitamin B complex, carotene, and vitamin E, and may further comprise a fragrance, a thickening agent and a surfactant. The pharmaceutical composition is for topical application and is useful in skin-care and for the treatment of acne, comedo and zit. The composition also has an antioxidant property.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: February 2, 2010
    Assignee: HenKan Pharmaceutical Co., Ltd.
    Inventors: BuSang Liu, TongHo Lin